See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Ativan, Tavor, APO-Lorazepam
What is Lorazepam? Lorazepam is a benzodiazepine used in the treatment of anxiety disorders. It is used intravenously for status epilepticus. Off label it is used for alcohol detoxification; insomnia; partial complex seizures; agitation; and as an adjunct in antiemetic treatment.
See more information, including instructions, precautions, side effects, and interactions.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Anxiety | 57 | 48% |
| Other | 17 | 14% |
| Insomnia | 8 | 6% |
| disease-related symptoms | 3 | 2% |
| periods of shortness of breath or breathing hard after almost no activiity | 3 | 2% |
| General health | 2 | 1% |
| Anxiety and frustration | 1 | <1% |
| Fasciculations | 1 | <1% |
| shaky all over | 1 | <1% |
| Sleepiness | 1 | <1% |
| 0.01mg as needed | 0.25mg as needed | 0.5 mg as needed | 0.5mg as needed | 0mg as needed | 1mg as needed | 20mg as needed | 2 mg all the time (24/7) | 2mg as needed | 2mg/mL as needed | 4 1mg as needed | 5mg as needed | daily | mg as needed | 0.25 mg daily | 0.5 mg daily | 1 mg daily | 1.5 mg daily | 2 mg daily | 3 mg daily | 4 mg daily | 8 mg daily | 12 mg daily | 15 mg daily | 20 mg daily | 25 mg daily | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1
|
1
|
3
|
16
|
1
|
9
|
1
|
1
|
1
|
3
|
1
|
2
|
3
|
1
|
1
|
9
|
18
|
7
|
6
|
3
|
7
|
1
|
1
|
1
|
1
|
1
|
||
How long current patients have been taking Lorazepam or how long patients were taking Lorazepam before stopping.
Results from 4 patient evaluations. See the overall results and all individual evaluations.
There is currently no efficacy data for Lorazepam.
| Severe | 0% | 0 |
|---|---|---|
| Moderate | 0% | 0 |
| Mild | 50% | 2 |
| None | 50% | 2 |
Top reported side-effects include: Drowsiness, Sedation, Increase in balance difficulties
Summary results are based on 4 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Report created on November 07, 2009.